RETA – Vitacellelabs
US$ 22.39
glp 1 for addiction What to know about how GLP-1 medications might fight GLP-1 meds show promise for
Description
You are unable to take oral fluids
doi:10.1016/j.molmet.2021.101181 64
The risk of gastrointestinal adverse events is increased with GLP-1RA therapy but these effects tend to be mild-to-moderate and transient, and are not the reason for observed weight loss
In neurodegenerative disease models, the co-delivery of GLP-1 analogues and conformation-specific antibodies against A or -syn has achieved concurrent neuroprotection and proteopathy clearance, leading to sustained behavioral and histological improvements [437, 438]
